UBA3 and cancer: A previously identified NAE inhibitor showed broad activity against cancer cell lines, and the authors used molecular docking against a quaternary complex comprising the NAE subunits APPBP1 and UBA3 as well as its NEDD8 and ATP substrates to identify the new compound which showed low micromolar activity in Caco-2 cells [41].